Monday, December 1, 2008 - 11:01PM EST

Clinical Trials

11. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).

Author
Oertel WH; Stiasny-Kolster K; Bergtholdt B; Hallstrom Y; Albo J; Leissner L; Schindler T; Koester J; Reess J;
Institution
Philipps-University Marburg, Marburg, Germany. oertelw@med.uni-marburg.de
Journal
Mov Disord. 2007 Jan 15;22(2):213-9.
Abstract URL
Click here to view abstract

12. Exercise and restless legs syndrome: a randomized controlled trial.

Author
Aukerman MM; Aukerman D; Bayard M; Tudiver F; Thorp L; Bailey B; Aukerman MM; Aukerman D; Bayard M; Tudiver F; Thorp L; Bailey B;
Institution
Department of Kinesiology, Pennsylvania State University, Pennsylvania, USA.
Journal
J Am Board Fam Med. 2006 Sep-Oct;19(5):487-93.
Abstract URL
Click here to view abstract

13. Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study.

Author
McCrink L; Allen RP; Wolowacz S; Sherrill B; Connolly M; Kirsch J;
Institution
RTI Health Solutions, Williams House, Manchester Science Park, Manchester, Lancashire M15 6SE, UK. lmccrink@rti.org
Journal
Sleep Med. 2007 Jan;8(1):73-83. Epub 2006 Oct 4.
Abstract URL
Click here to view abstract

14. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).

Author
Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K; Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K; Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K;
Institution
Department of Neurology, Center of Nervous Diseases, Philipps-University Marburg, Rudolf-Bultmann-Str. 8, D-35033 Marburg, Germany. oertelw@med.uni-marburg.de
Journal
Neurology. 2006 Sep 26;67(6):1040-6. Epub 2006 Aug 23.
Abstract URL
Click here to view abstract

15. Efficacy and safety of pramipexole in restless legs syndrome.

Author
Winkelman JW; Sethi KD; Kushida CA; Becker PM; Koester J; Cappola JJ; Reess J; Winkelman JW; Sethi KD; Kushida CA; Becker PM; Koester J; Cappola JJ; Reess J;
Institution
Division of Sleep Medicine, Brigham and Women's Hospital Sleep Health Center, 1505 Commonwealth Avenue, Brighton, MA 02135, USA. jwwinkelman@partners.org
Journal
Neurology. 2006 Sep 26;67(6):1034-9. Epub 2006 Aug 23.
Abstract URL
Click here to view abstract

16. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.

Author
Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J;
Institution
Skogby Sleep Clinic, Rinnekoti Research Centre, Kumputie 3, FI-02980 Espoo, Finland. markku.partinen@rinnekoti.fi
Journal
Sleep Med. 2006 Aug;7(5):407-17. Epub 2006 Jul 3.
Abstract URL
Click here to view abstract

17. Actometry in measuring the symptom severity of restless legs syndrome.

Author
Tuisku, K; Holi, M M; Wahlbeck, K; Ahlgren, A J; Lauerma, H;
Institution
Department of Psychiatry, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Journal
Eur J Neurol 2005 May;12(5):385-7.
Abstract URL
Click here to view abstract

18. Apomorphine in idiopathic restless legs syndrome: an exploratory study.

Author
Tribl, G G; Sycha, T; Kotzailias, N; Zeitlhofer, J; Auff, E;
Institution
Department of Neurology, University of Vienna, Waehringer Guertel 18-20, A-1097 Vienna, Austria. gotthard.tribl@meduniwien.ac.at
Journal
J Neurol Neurosurg Psychiatry 2005 Feb;76(2):181-5.
Abstract URL
Click here to view abstract
Pages: 1 2